학술논문
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
Document Type
Article
Author
Wainberg, Zev A ; Melisi, Davide; Macarulla, Teresa; Pazo Cid, Roberto; Chandana, Sreenivasa R; De La Fouchardière, Christelle; Dean, Andrew; Kiss, Igor; Lee, Woo Jin; Goetze, Thorsten O; Van Cutsem, Eric; Paulson, A Scott; Bekaii-Saab, Tanios; Pant, Shubham; Hubner, Richard A; Xiao, Zhimin; Chen, Huanyu; Benzaghou, Fawzi; O'Reilly, Eileen M
Source
In The Lancet 7-13 October 2023 402(10409):1272-1281
Subject
Language
ISSN
0140-6736